Mots-clés
Documents disponibles dans cette catégorie (837)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Etendre la recherche sur niveau(x) vers le bas
Article
Article
Article
Article
Article
Article
Article
Labrador E ; Weinstein DA | 27/11/2019Initial Posting: April 23, 2009; Last Update: November 27, 2019. Clinical characteristics. Glycogen storage disease type VI (GSD VI) is a disorder of glycogenolysis caused by deficiency of hepatic glycogen phosphorylase. This critical enzy[...]Article
Article
Article
Kimonis V | 12/09/2019Initial Posting: May 25, 2007; Last Update: September 12, 2019. Clinical characteristics. Inclusion body myopathy associated with Paget disease of bone (PDB) and/or frontotemporal dementia (IBMPFD) is characterized by adult-onset proximal [...]Article
Penttila S ; Vihola A ; Palmio J ; Udd B | 22/08/2019Initial Posting: November 29, 2012; Last Update: August 22, 2019. Clinical characteristics. The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal m[...]Article
Bonne G ; Leturcq F ; Ben Yaou R | 15/08/2019Initial Posting: September 29, 2004; Last Update: August 15, 2019. Clinical characteristics. Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of: joint contractures that begin in early childhood; slowly progr[...]Article
Magoulas PL ; El-Hattab AW | 01/08/2019Initial Posting: January 3, 2013; Last Update: August 1, 2019. Clinical characteristics. The clinical manifestations of glycogen storage disease type IV (GSD IV) discussed in this entry span a continuum of different subtypes with variable ag[...]Article
Saito K | 03/07/2019Initial Posting: January 26, 2006; Last Update: July 3, 2019. Clinical characteristics. Fukuyama congenital muscular dystrophy (FCMD) is characterized by hypotonia, symmetric generalized muscle weakness, and CNS migration disturbances that[...]Article
Initial Posting: April 19, 2006; Last Update: June 20, 2019. Clinical characteristics. Glycogen storage disease type V (GSDV, McArdle disease) is a metabolic myopathy characterized by exercise intolerance manifested by rapid fatigue, myalgia[...]Article
Initial Posting: June 20, 2019. Clinical characteristics. STAC3 disorder is characterized by congenital myopathy, musculoskeletal involvement of the trunk and extremities, feeding difficulties, and delayed motor milestones. Most affected ind[...]Article
Initial Posting: August 5, 2008; Last Update: June 6, 2019. The purpose of this overview is to increase clinician awareness of the genetic basis of hypertrophic cardiomyopathy (HCM) and the benefits of early diagnosis and management to indivi[...]Article
Hackman P ; Savarese M ; Carmignac V ; Udd B ; Salih MA | 11/04/2019Initial Posting: January 12, 2012; Last Update: April 11, 2019. Clinical characteristics. Salih myopathy is characterized by muscle weakness (manifest during the neonatal period or in early infancy) and delayed motor development; children ac[...]Article
Wieser T | 03/01/2019Initial Posting: August 27, 2004; Last Revision: January 3, 2019. Clinical characteristics. Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal n[...]Article
Okur D ; Daimaguler HS ; Danyeli AE ; Tekgul H ; Wang H ; Wunderlich G ; Cirak S ; Yis U | Turkey | 2019Article
El-Hattab AW ; Almannai M ; Scaglia F | 29/11/2018Initial Posting: February 27, 2001; Last Update: November 29, 2018. Clinical characteristics. MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) is a multisystem disorder with protean manifestations. The vast [...]Article
Herbert M ; Goldstein JL ; Rehder C ; Austin S ; Kishnani PS ; Bali DS | 01/11/2018Initial Posting: May 31, 2011; Last Update: November 1, 2018. Clinical characteristics. Phosphorylase kinase (PhK) deficiency causing glycogen storage disease type IX (GSD IX) results from deficiency of the enzyme phosphorylase b kinase, whi[...]Article
Dowling JJ ; Lawlor MW ; Das S | 23/08/2018Initial Posting: February 25, 2002; Last Update: August 23, 2018. Clinical characteristics. X-linked myotubular myopathy (X-MTM), also known as myotubular myopathy (MTM), is characterized by muscle weakness that ranges from severe to mild. [...]